BMJ Group Board Members
Chairman
Deputy Chairman
Directors
Non-Executive Board Members
Jay Lippincott
Observer and Treasurer - BMA
BMJ Group Board Member profiles and pictures
Dr Michael Chamberlain
Chairman
Michael has been Chairman of BMJ Group and a Director of the BMA since 2004. He also serves as a Director and Alternate Chairman on the Board of the BNF (the British National Formulary). He is a Trustee of MedFASH, the Medical Foundation for AIDS and Sexual Health (since 2006).
Previously he headed IBM’s Business Consultancy Services in Media & Entertainment in EMEA, and prior to this was founder Editor/Publisher of Marketing Week magazine in the UK and Managing Director of Centaur Business Publishing (1978-89).
Michael has a Ph.D. in Communications (1993, Florida State University) and Bachelor’s and Master’s degrees in Economics and Social Studies from the University of Manchester.
Dr Brian Keighley
Deputy Chairman
Brian has been a general practitioner in the same practice on the East side of Loch Lomond since 1974. He has combined his rural general practice with a parallel career within the BMA since 1978 when he was elected to his Local Medical Committee. He has been a member of Scottish GPC continuously since that time, chairing the committee between 1995 and 1998, and chaired the Joint Committee on Postgraduate Training for General Practice between 1997 and 2000.
He was deputy chairman of the Scottish Council for Postgraduate Medical and Dental Education, a founder member of the Clinical Standards Board for Scotland and has most recently served as Treasurer of the General Practitioners Defence Fund Ltd, GPC member and member of BMA Council (UK). He is currently Deputy Chairman of BMA Scotland and served as a member of the Journal Committee and as a director of BMJ Group for over ten years.
Mrs Stella Dutton
CEO, BMJ Group
Stella joined the BMJ Group as Executive Director, with responsibility for business and operational issues, in 1996, and became CEO in 2004. Before joining BMJ Group she worked for Reed International as Publishing Director for their Science Division. She has also been the Director of Publications at the Royal Pharmaceutical Society. Stella has a Chemistry degree from London University and lives in Surrey.
Mr Patrick Spencer
Finance Director, BMJ Group
Patrick joined BMJ Group as Finance Director in 2004. Prior to joining the BMJ he spent 7 years in various financial roles within De La Rue plc, a FTSE 250 company, including 3 years as Finance Director of the Security Print Division. He qualified as a Chartered Accountant with KPMG in 1993 and has a degree in mathematics.
Dr Fiona Godlee
Editor, BMJ
Fi has been editor in chief of the BMJ since 2005. She qualified as a doctor in 1985, trained as a general physician in Cambridge and London, and is a Fellow of the Royal College of Physicians. Since joining the BMJ in 1990 she has written on a broad range of issues, including the impact of environmental degradation on health, the future of the World Health Organization, the ethics of academic publication, and the problems of editorial peer review.
In 1994 she spent a year at Harvard University as a Harkness Fellow, evaluating efforts to bridge the gap between medical research and practice. On returning to the UK, she led the development of Clinical Evidence, which evaluates the best available evidence on the benefits and harms of treatments and is now provided worldwide to over a million clinicians in 9 languages through BMJ Group.
Non-Executive Board Members
Jay Lippincott has more than 35 years of experience in scientific, technical, and medical publishing. He has served as an advisor to the BMJ Group since 2009. He was formerly president and CEO of the Professional & Education Unit of Wolters Kluwer’s Health Division, an international publisher for students and professionals in medicine, nursing, and the allied health professions. Prior to that, Mr. Lippincott was president and CEO of Kluwer Academic Publishers, an international publisher of academic and professional research. He was also president of Lippincott Williams & Wilkins, Lippincott-Raven Publishers, and Raven Press, and before that held numerous executive positions at J.B. Lippincott Company.
Mr Tony Bourne
CEO and Secretary of the BMA
Tony left over 25 years of banking to join the BMA as Secretary/Chief Executive in January, 2005. He was a founding partner of Hawkpoint in its new form and previously he was at Paribas where he was Global Head of the Equity Division, a member of the Managing Board of the Group and a member of its worldwide Corporate Finance Committee. Prior to that he was at Merrill Lynch's London and New York offices.
He is a member of the main board of Southern Housing Group where he has chaired its Audit Committee and its Finance Committee and where he is currently chair of the Remuneration and Nominations Committee. From 2004 until 2007 Tony was on the Board of Trustees of Scope.
Dr Justin Whatling
Justin is the Chief Clinical Officer leading health strategy and clinical assurance for BT Health. He trained in medicine in London and has a degree in molecular biology. He has worked at a number of teaching centres and was previously a hospital physician in the field of neurology. Since Justin has acquired nine years experience of health-IT in the business sector with a special interest in wellbeing, health outcomes and health informatics.
Dr David Berger
David grew up in Switzerland and qualified in medicine in 1991 from St. George's Hospital Medical School in Tooting, along with his wife, Carol. He spent several years training in general medicine in London before they both had short spells working in the Solomon Islands and Switzerland. On returning to the UK in 1996 they started training in general practice in Barnstaple in North Devon, where they have remained ever since.
Sir Ian Gilmore
Professor Sir Ian Gilmore has just demitted office as President of the Royal College of Physicians after four years and is President-elect of the British Society of Gastroenterology. He is a consultant physician and astroenterologist with particular interest in liver disease at the Royal Liverpool University Hospital where he was medical director for four years. He was knighted in the 2010 Queen's Birthday Honours. He chairs the Alcohol Health Alliance UK and was a commissioner for the recent review of the social determinants of health chaired by Sir Michael Marmot.
Dr Arvind Singh
Dr Arvind Singh is consultant ophthalmic surgeon in vitreoretinal services with the Ayrshire and Arran Acute NHS Trust in Ayr, Scotland where he has worked for the last 13 years including holding the post of Clinical Director, Ophthalmology. He was previously Director of the Ophthalmology Programme at the HCI International Medical Centre in Clydebank Glasgow.
Dr Andrew Dearden
Observer and Treasurer - BMA
Dr Andrew Dearden was born in 1962 in Gilfach Goch, South Wales. He grew up in Australia, lived in New Zealand and has been back in Wales since 1979. He went to medical school in Cardiff and has worked as a GP in central Cardiff, South Wales since 1994. Has served as Chairman of BMA's Community Care Committee, Chairman of GPC Wales, UK GPC Negotiator, Member BMA UK and Wales Council and Chairman of BMA Pensions Committee. He was elected Treasurer of the BMA in ARM 2011.
